Status:

COMPLETED

Effect of Valsartan on Carotid Artery Disease

Lead Sponsor:

Emory University

Conditions:

Carotid Artery Diseases

Atherosclerosis

Eligibility:

All Genders

21-80 years

Phase:

PHASE2

Brief Summary

The EFFERVESCENT trial is designed to evaluate the effects of a specific ARB, called valsartan, on atherosclerosis. The investigators want to know if treatment with valsartan will increase the blood l...

Detailed Description

Atherosclerosis or 'hardening of the arteries' is a process that ultimately leads to the development of heart attacks, strokes, poor circulation, and death. Millions of Americans are affected by this ...

Eligibility Criteria

Inclusion

  • \> 0.65 mm intima-media thickness of the carotid artery measured by ultrasound
  • Males aged 21-80 years or women without child bearing potential up to age 80
  • Can be on concomitant therapy with aspirin, thiazide diuretics, calcium antagonists (for treatment of hypertension), or beta-receptor antagonists.
  • May be on statin if on stable dose for at least 2 months before recruitment

Exclusion

  • Angiotensin-converting enzyme (ACE) inhibitor or ARB therapy in the previous 3 months.
  • Initiation or change in dose of statin therapy within 2 months before the study
  • Inability to return to Emory for follow-up blood drawing and MR imaging
  • Age \< 21 or \> 80 years
  • Premenopausal females with potential for pregnancy
  • Current neoplasm
  • Chronic renal failure \[creatinine \> 2.5 mg/dL\]
  • Diabetes with hemoglobin (Hb) A1c \> 8.5
  • Anticipated change in lipid lowering therapy
  • Inability to give informed consent
  • MR exclusion criteria
  • Blood pressure \> 140 mmHg systolic and \> 90 mmHg diastolic
  • Low-density lipoprotein (LDL) cholesterol level \>130 mg/dl
  • Acute coronary syndrome within 2 months
  • Acute cerebrovascular accident within 2 months

Key Trial Info

Start Date :

February 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2009

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT00208767

Start Date

February 1 2005

End Date

November 1 2009

Last Update

December 8 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Emory University School of Medicine

Atlanta, Georgia, United States, 30322